ScourGuard 4® KC
Bovine Rota-Coronavirus Vaccine Killed Virus-Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid
Protect Calves Before They Hit the Ground

ScourGuard 4® KC is administered to the pregnant dam and has been protecting calves for more than 14 years. Cows and first-calf heifers administered ScourGuard deliver antibody-rich colostrum that protects against the major causes of calf scours: E. coli bovine rotavirus bovine coronavirus and Clostridium perfringens Type C.

Approved Uses
ScourGuard 4 is approved for the vaccination of healthy pregnant cows and first-calf heifers as an aid in passive maternal immunization of their calves against neonatal calf diarrhea caused by rotavirus coronavirus E. coli having the K99 pili adherence factor and Clostridium perfringens Type C.

Key Advantages
Scours is responsible for 62.1% of deaths among unweaned dairy calves.1 Losses don??t end there however as animals that survive can be set back permanently. Heifers that suffered scours early in life tend to enter the milking string later than heifers that remained scours-free as calves. Unfortunately despite good management almost all calves are exposed to one or more infectious agents that cause scours.

Broad-spectrum ScourGuard delivers time-tested protection:

• Demonstrates reduced shedding of coronavirus in cows and rotavirus in calves
• Strong protection against rotavirus
• Delivers powerful tissue-friendly protection

Dosage/Administration
Proper vaccination with ScourGuard 4 KC requires:

• Pregnant females to receive two 2-mL doses at least 2 weeks apart as their primary vaccination with the second dose given 2 to 3 weeks prior to calving
• Annual revaccination with a single dose 2 to 3 weeks before each subsequent calving is recommended

If cows have not calved within 40 days after their last dose then revaccination with a single dose is recommended. All vaccinations should be given intramuscularly in the muscular region of the neck.

Precautions

• Store at 2°-° C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.
• Use entire contents when first opened.
• Sterilized syringes and needles should be used to administer this vaccine
• This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease are malnourished or parasitized are stressed due to shipment or environmental conditions are otherwise immunocompromised or if the vaccine is not administered according to label directions.

As with many vaccines anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.